INS and coronary artery disorder: Studies in human subjects have identified increased FGF-21 levels in cardiometabolic pathologies such as non-alcoholic fatty liver disease, coronary artery disease, diastolic heart failure, diabetes, and insulin resistance, mediating the adaptive response to various stresses [33].